Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 3, 2006, Pages 1210-1218

  Yuan, Jie ^a   Hatzidimitriou, George ^a   Suthar, Pranav ^a   Mueller, Melanie ^b   McCann, Una ^a   Ricaurte, George ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAARLAND UNIVERSITY   (Germany)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORE TEMPERATURE; CORRELATION ANALYSIS; DOPAMINERGIC ACTIVITY; DRUG BLOOD LEVEL; DRUG EXPOSURE; ENVIRONMENTAL TEMPERATURE; HYPERTHERMIA; METABOLISM; METABOLITE; MONOAMINE NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RODENT; SQUIRREL MONKEY;

ANIMALS; BODY TEMPERATURE; CORPUS STRIATUM; FEMALE; MALE; METHAMPHETAMINE; SAIMIRI;

EID: 33644760488     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.096503     Document Type: Article

References (60)

1. Albers DS and Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and non-protective agents. J Pharmacol Exp Ther 275:1104-1114.
2. Ali SF, Newport GD, Holson RR, Slikker W Jr, and Bowyer JF (1994) Low hypothermia decreases methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
3. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr, and Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580.
4. Bowyer JF and Holson RR (1995) Methamphetamine and amphetamine neurotoxicity: characteristics, interactions with body temperature and possible mechanisms, in Handbook of Neurotoxicology (Chang LW and Dyer RS eds) vol. II, pp 845-870, Marcel Dekker, New York.
5. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF, and Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824.
6. 2+ exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity. J Neurochem 77:1348-1362.
7. Callahan B, Yuan J, Stover G, Hatzidimitriou G, and Ricaurte G (1998) Effects of 2-deoxy-D-glucose on methamphetamine-induced dopamine and serotonin neurotoxicity. J Neurochem 70:190-197.
8. Clausing P, Gough B, Holson RR, Slikker W Jr, and Bowyer JF (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 274:614-621.
9. Cho AK and Melega WP (2002) Patterns of methamphetamine abuse and their consequences. J Addict Dis 21:21-34.
10. Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, and Perez-Reyes M (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21:717-723.
11. Cook CE, Jeffcoat AR, Sadler BM, Hill JM, Voyksner RD, Pugh DE, White WR, and Perez-Reyes M (1992) Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos 20:856-862.
12. Cubells JF, Rayport S, Rajindron G, and Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular stress. J Neurosci 14:2260-2771.
13. Emmers R and Akert K (1963) A Stereotaxic Atlas of the Brain of the Squirrel Monkey (Saimiri sciureus), The University of Wisconsin Press, Madison, WI.
14. Farfel GM and Seiden LS (1995) Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J Pharmacol Exp Ther 272:868-875.
15. Fukumura M, Cappon G, Cunfeng P, Broening H, and Vorhees C (1998) A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostratal monoamines and glial fibrillary acidic protein. Brain Res 806:1-7.
16. Fuller CA, Sulzman FM, and Moore-Ede MC (1979) Circadian control of thermoregulation in the squirrel monkey (Saimiri sciureus). Am J Physiol 236:R153-R161.
17. Fumagalli F, Gainetdinov RR, Valenzano KJ, and Caron MG (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci 18:4861-4869.
18. Gibb JW, Hanson GR, and Johnson M (1994) Neurochemical mechanisms of toxicity, in Amphetamine and Its Analogs (Cho AK and Segal DS eds) pp 269-295, Academic Press, San Diego, CA.
19. Giovanni A, Liang LP, Hastings TG, and Zigmond MJ (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 64:1819-1825.
20. Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, and Sonsalla PK (2001) Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 79:152-160.
21. Gygi MP, Gygi SP, Johnson M, Wilkins DG, Gibb JW, and Hanson GR (1996) Mechanisms for tolerance to methamphetamine effects. Neuropharmacology 35:751-757.
22. Hotchkiss AJ and Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257-262.
23. Johnson-Davis KL, Fleckenstein AE, and Wilkins DG (2003) The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur J Pharmacol 482:151-154.
24. Kalant OJ (1966) The Amphetamines: Toxicity and Addiction. Charles C Thomas, Springfield, IL.
25. Kyle DA and Hansell B (2005) The METH Epidemic in America. Two Surveys of US Counties. National Association of Counties, Washington, DC.
26. Lew R, Malberg JE, Ricaurte GA, and Seiden LS (1997) Evidence for the mechanism of action of neurotoxicity of amphetamine related compounds, in Highly Selective Neurotoxins: Basic and Clinical Applications (Kostrzewa RM ed) pp 235-268, Humana Press, Totowa, NJ.
27. Marek GJ, Vosmer G, and Seiden LS (1990) Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res 513:274-279.
28. McCann UD and Ricaurte GA (2004) Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci Biobehav Rev 27:821-826.
29. McCann UD, Wong DF, and Yokoi F (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 18:8417-8422.
30. Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, and Ricaurte GA (2005) Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons. Neuropsychopharmacology, in press.
31. 11C]WIN 35,428 - positron emission tomography studies. Neurosci Lett 258:17-20.
32. Melega WP, Raleigh MJ, Stout DB, Lacan G, and Huang SC (1997) Recovery of striatal dopamine function after acute amphetamine- and methamphetamineinduced neurotoxicity in the vervet monkey. Brain Res 766:113-120.
33. Miller DB and O'Callaghan JP (1994) Environment-, drug- and stress-induced alterations in core temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
34. Miller DB and O'Callaghan JP (2003) Elevated environmental temperature and methamphetamine neurotoxicity. Environ Res 92:48-53.
35. Miller M and Hughes A (1994) Epidemiology of amphetamine use in the United States, in Amphetamine and Its Analogs: Neuropsychopharmacology, Toxicology and Abuse (Cho AK and Segal DS eds) pp 439-458, Academic Press, New York.
36. Nakashima K, Kaddoumi A, Ishida Y, Itoh T, and Taki K (2003) Determination of methamphetamine and amphetamine in abusers' plasma and hair samples with HPLC-FL. Biomed Chromatogr 17:471-476.
37. O'Callaghan JP and Miller D (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751.
38. Peters FT, Samyn N, Wahl M, Kraemer T, De Boeck G, and Maurer HH (2003a) Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. J Anal Toxicol 27:552-559.
39. Peters FT, Schaefer S, Staack RF, Kraemer T, and Maurer HH (2003b) Screening for and validated quantification of amphetamines and of amphetamine-and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom 38:659-676.
40. Pu C, Fisher JE, Cappon GD, and Vorhees CV (1994) The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res 649:217-224.
41. Ricaurte GA, Guillery RW, Seiden LS, and Schuster CR (1984a) Nerve terminal degeneration after a single injection of d-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion. Brain Res 291:378-382.
42. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, and Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235:93-103.
43. Ricaurte GA, Schuster CR, and Seiden LS (1980) Long-term effects of repeated methyl-amphetamine administration on dopaminergic and serotonergic neurons in the rat brain: a regional study. Brain Res 193:153-160.
44. Ricaurte GA, Seiden LS, and Schuster CR (1984b) Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res 303:359-364.
45. Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, and Fleckenstein AE (2002) Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur J Pharmacol 435:181-185.
46. Robinson EL, Demaria-Pesce VH, and Fuller CA (1993) Circadian rhythms of thermoregulation in the squirrel monkey (Saimiri sciureus). Am J Physiol 265:R781-R785.
47. Robinson EL and Fuller CA (1999) Endogenous thermoregulatory rhythms of squirrel monkeys in thermoneutrality and cold. Am J Physiol 276:R1397-R1407.
48. Schepers RJ, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, and Huestis MA (2003) Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 49:121-132.
49. Schmidt CJ, Sonsalla PK, Hanson GR, Peat MA, and Gibb JW (1985) Methamphetamine-induced depression of monoamine synthesis in the rats: development of tolerance. J Neurochem 44:852-855.
50. Seiden LS and Ricaurte GA (1987) Neurotoxicity of methamphetamine and related drugs, in Psychopharmacology - The Third Generation of Progress (Meltzer HY ed) pp 359-366, Raven Press, New York.
51. Seiden LS and Sabol KE (1996) Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr 163:251-276.
52. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, and Mori N (2001) Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 158:1206-1214.
53. Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, and Hall ED (1996) Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res 38:172-175.
54. Stephans T and Yamamoto B (1996) Methamphetamine pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience 72:593-600.
55. Stitt JT and Hardy JD (1971) Thermoregulation in the squirrel monkey (Saimiri sciureus). J Appl Physiol 31:48-54.
56. Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB, Ravert HT, Musachio J, McCann UD, and Ricaurte GA (1998) Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18:419-427.
57. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, et al. (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377-382.
58. Xie T, McCann UD, Kim S, Yuan J, and Ricaurte GA (2000) Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity. J Neurosci 20:7838-7845.
59. Yamamoto BK and Zhu W(1998) The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 287:107-114.
60. Yuan J, Callahan BT, McCann UD, and Ricaurte GA (2001) Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. J Neurochem 77:1338-1347.